Log In

MAIA Biotechnology Inc. (MAIA)

THIO-101 Part A Shows Safety And Tolerability

‌
Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
April 12, 2023
Report ID: 25742
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.
Get Report

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

‌
MAIA Biotechnology Inc.
MAIA Biotechnology Inc.
Healthcare
Biotechnology
Ticker
MAIA
Current Price
$1.8 11.8%
Market Cap
$24.5M
Price Target
Refer to Report
Volume
125.7K
52wk Range
$1.42 - $5.22
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
Related Research Reports
8/9/2023
‌
2Q23 Reported With Trial Enrollment Making Progress
2Q23 Reported With Trial Enrollment Making Progress (MAIA)
0 min read
7/11/2023
‌
THIO-101 Part A Survival Data Reaches 12 Months
THIO-101 Part A Survival Data Reaches 12 Months (MAIA)
0 min read
6/21/2023
‌
Phase 2 THIO-101 Trial Reaches Recruitment Milestone
Phase 2 THIO-101 Trial Reaches Recruitment Milestone (MAIA)
3 min read
5/9/2023
‌
1Q23 Reported As Trial Progress Continues
1Q23 Reported As Trial Progress Continues (MAIA)
0 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In